• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Higher SARS-CoV-2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant

tetano

Editor, Senior Moderator
J Med Virol


. 2022 Dec 2.
doi: 10.1002/jmv.28365. Online ahead of print.
Higher SARS-CoV-2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant


Jiaming Li[SUP] 1 [/SUP], Jing Zheng[SUP] 2 [/SUP], Peng Chen[SUP] 3 [/SUP], Baochun Wang[SUP] 4 [/SUP], Yidun Zhang[SUP] 2 [/SUP], Jinwei Xiong[SUP] 3 [/SUP], Liuping You[SUP] 3 [/SUP], Yifei Jin[SUP] 1 [/SUP], Lina Jiang[SUP] 2 [/SUP], Fei Tang[SUP] 2 [/SUP], Huixin Wen[SUP] 2 [/SUP], Chao Hong[SUP] 2 [/SUP], Xiaohong Zeng[SUP] 2 [/SUP], Li Li[SUP] 2 [/SUP], Bing Lu[SUP] 1 [/SUP], Biao Rong[SUP] 2 [/SUP], Zhongyi Wang[SUP] 1 [/SUP]



Affiliations

Abstract

The global pandemic of the BA.5 subvariant had moved from prediction to reality. In this study, we compared SARS-CoV-2 aerosol emissions from patients with BA.2 or BA.5 subvariant infection. First, patients with BA.2 subvariant infection had higher upper respiratory viral loads than patients with BA.5 subvariant infection. However, the average breath emission rate (BER) of patients with BA.5 subvariant infection, which represented the concentration of exhaled SARS-CoV-2 aerosols, was nearly 40 times higher than that of patients with BA.2 subvariant. Second, aerosols exhaled by patients with BA.5 subvariant infection exhibited SARS-CoV-2 RNA detection positive rate than patients with BA.1 or BA.2 subvariant infection. Meanwhile, for BA.5 subvariant infection, patients that exhaled infectious SARS-CoV-2 aerosols accounted for 14.8% of all patients. Third, since the onset of COVID-19, the SARS-CoV-2 RNA detection signals of throat swabs showed a gradual decline trend, although the decline process was accompanied by fluctuations. Overall, the monitoring of infectious SARS-CoV-2 aerosols may provide the data support for the transmissibility evaluation of the Omicron BA.5 subvariant. This article is protected by copyright. All rights reserved.

Keywords: Epidemiology; Infection; Local infection/Replication/Spread; Pathogenesis; Respiratory tract; SARS coronavirus; Virus classification.
 
Back
Top Bottom